Tags Archive Navigation
icon
-
Media ReleaseNovartis post hoc analysis shows high-dose Enerzair® Breezhaler® reduces asthma exacerbations versus medium-dose, complementing key pivotal IRIDIUM study findings
-
StoryThe search for new options for patients with lung cancer
-
StoryOn being and becoming a data science company
-
StoryInspiring a daughter to make her own path
-
StoryThe future of chronic myeloid leukemia is evolving
-
StorySeeing through knees in quest to alleviate osteoarthritis
-
StoryHow a 19th-century technology is speeding up drug discovery
-
StoryAdvancing medicine through collaboration
-
StoryVisualizing molecular glues
-
StoryToward improving the health and longevity of transplanted organs
-
StorySourcing innovation, strategically
-
StoryGuidance system lights a path for drug discovery
Pagination
- ‹ Previous page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- …
- 16
- › Next page